4Jemal A,Siegel R,Xu J,et al.Cancer statistics 2010[J].CA Cancer J Clin,2010,60(5):277-300.
5Ferlay J,Shin HR,Bray F,et al.Estimates of worldwide burden of Ca-ner in 2008[J].Int J Caneer,2010,127(12);2893-2917.
6JEMAL A, SIEGEL R, XU J, et al. Cancer statistics, 2010 [ J ]. CA Cancer J Clin, 2010, 60(5):277-300.
7APTE S S. A disintegrin-like and metalloprotease (reprolysin- type) with thrombospondin type 1 motif (ADAMTS) superfamily: functions and mechanisms [ J - . J Biol Chem, 2009, 284(46): 31493-31497.
8VILORIA C G, OBAYA A J, MONCADA-PAZOS A, et al. Genetic inactivation of ADAMTS15 metalloprotease in human colorectal cancer [ J ]. Cancer Res, 2009, 69(11): 4926- 4934.
9DU W, WANG S, ZHOU Q, et al. ADAMTS9 is a functional tumor suppressor through inhibiting AKT/mTOR pathway and associated with poor survival in gastric cancer [ J - . Oncogene, 2013, 32(28): 3319-3328.
10PENG L, YANG Z, TAN C, et al. Epigenetic inactivation of ADAMTS9 via promoter methylation in multiple myeloma [ J ] . Mol Med Rep, 2013, 7(3): 1055-1061.
